Zobrazeno 61 - 70
of 425
pro vyhledávání: '"Kazuko Sakai"'
Autor:
Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kazuto Nishio, Kazuko Sakai, Koji Haratani, Yasutaka Chiba, Akihiro Bessho, Kazumi Nishino, Motoko Tachihara, Shota Omori, Koichi Azuma, Junko Tanizaki, Satoshi Hara, Yuichi Ozawa, Keiichi Ota, Satoru Miura, Daichi Fujimoto, Yasushi Fukuda, Shunichi Sugawara, Hidetoshi Hayashi
Supplementary Data from A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edb380ecd1bb3a3d55383731ac57703
https://doi.org/10.1158/1078-0432.22487289
https://doi.org/10.1158/1078-0432.22487289
Autor:
Kazuto Nishio, Kazuhiko Nakagawa, Isamu Okamoto, Junji Tsurutani, Yasuhide Yamada, Yoshihiko Fujita, Kazuko Matsumoto, Marco A. De Velasco, Kazuko Sakai, Kanae Kudo, Keiichi Aomatsu, Daisuke Tamura, Kaoru Tanaka, Tokuzo Arao, Hiroyasu Kaneda
Supplementary Figure Legend from FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b8b7bc91f66a0e6ced42ed7083e7df6
https://doi.org/10.1158/0008-5472.22386614
https://doi.org/10.1158/0008-5472.22386614
Autor:
Kazuto Nishio, Kazuhiko Nakagawa, Isamu Okamoto, Junji Tsurutani, Yasuhide Yamada, Yoshihiko Fujita, Kazuko Matsumoto, Marco A. De Velasco, Kazuko Sakai, Kanae Kudo, Keiichi Aomatsu, Daisuke Tamura, Kaoru Tanaka, Tokuzo Arao, Hiroyasu Kaneda
Supplementary Figure 1 from FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07020214d3209a341d1583152d808922
https://doi.org/10.1158/0008-5472.22386617
https://doi.org/10.1158/0008-5472.22386617
Autor:
Kazuto Nishio, Kazuhiko Nakagawa, Isamu Okamoto, Junji Tsurutani, Yasuhide Yamada, Yoshihiko Fujita, Kazuko Matsumoto, Marco A. De Velasco, Kazuko Sakai, Kanae Kudo, Keiichi Aomatsu, Daisuke Tamura, Kaoru Tanaka, Tokuzo Arao, Hiroyasu Kaneda
Supplementary Tables 1-2 from FOXQ1 Is Overexpressed in Colorectal Cancer and Enhances Tumorigenicity and Tumor Growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b1a5a0f8c882bc3b3118e0ed07d9d9
https://doi.org/10.1158/0008-5472.22386611.v1
https://doi.org/10.1158/0008-5472.22386611.v1
Autor:
Kazuto Nishio, Kazuhiko Nakagawa, Isamu Okamoto, Junji Tsurutani, Yasuhide Yamada, Yoshihiko Fujita, Kazuko Matsumoto, Marco A. De Velasco, Kazuko Sakai, Kanae Kudo, Keiichi Aomatsu, Daisuke Tamura, Kaoru Tanaka, Tokuzo Arao, Hiroyasu Kaneda
Forkhead box Q1 (FOXQ1) is a member of the forkhead transcription factor family, and it has recently been proposed to participate in gastric acid secretion and mucin gene expression in mice. However, the role of FOXQ1 in humans and especially in canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c158c8faadf5c7f14b84d15c273610
https://doi.org/10.1158/0008-5472.c.6501593
https://doi.org/10.1158/0008-5472.c.6501593
Autor:
Yusuke Makutani, Kazuko Sakai, Masahiro Yamada, Toshiaki Wada, Takaaki Chikugo, Takao Satou, Yoko Iwasa, Hidekazu Yamamoto, Marco A. de Velasco, Kazuto Nishio, Junichiro Kawamura
Publikováno v:
International Journal of Clinical Oncology. 27:1180-1187
Background The Biocartis Idylla™ platform is a fully automated, real-time PCR-based diagnostic system. The Idylla™KRAS and NRAS-BRAF Mutation Tests have been developed for the qualitative detection of mutations in KRAS, NRAS and BRAF genes, facil
Autor:
Masanobu Tsubaki, Tomoya Takeda, Yuuichi Koumoto, Takehiro Usami, Takuya Matsuda, Shiori Seki, Kazuko Sakai, Kazuto Nishio, Shozo Nishida
Publikováno v:
Cell Proliferation.
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
Autor:
Kentaro Tanaka, Kenji Chamoto, Sho Saeki, Ryusuke Hatae, Yuki Ikematsu, Kazuko Sakai, Nobuhisa Ando, Kazuhiro Sonomura, Shinsuke Kojima, Masanori Taketsuna, Young Hak Kim, Hironori Yoshida, Hiroaki Ozasa, Yuichi Sakamori, Tomoko Hirano, Fumihiko Matsuda, Toyohiro Hirai, Kazuto Nishio, Takuro Sakagami, Masanori Fukushima, Yoichi Nakanishi, Tasuku Honjo, Isamu Okamoto
Publikováno v:
Science translational medicine. 14(675)
Despite the success of cancer immunotherapies such as programmed cell death–1 (PD-1) and PD-1 ligand 1 (PD-L1) inhibitors, patients often develop resistance. New combination therapies with PD-1/PD-L1 inhibitors are needed to overcome this issue. Be
Publikováno v:
Translational Cancer Research. 11:295-298
Autor:
Masaki Kaibori, Kazuko Sakai, Hideyuki Matsushima, Hisashi Kosaka, Kosuke Matsui, Marco A. De Velasco, Mitsugu Sekimoto, Kazuto Nishio
Publikováno v:
Hepatology International. 16:135-147
Background/purpose of the study Tumor heterogeneity based on copy number variations is associated with the evolution of cancer and its clinical grade. Clonal composition (CC) represents the number of clones based on the distribution of B-allele frequ